Exercise-induced myocardial perfusion abnormalities in sickle β-thalassemia: Tc-99m tetrofosmin gated SPECT imaging study

American Journal of Medicine

Volumn 111, Issue 5, 2001, Pages 355-360

  Aessopos, Athanasios ^a,c   Tsironi, Maria ^a   Vassiliadis, Ioannis ^b   Farmakis, Dimitrios ^a   Fountos, Alexandros ^b   Voskaridou, Ersi ^c   Perakis, Alexandros ^c   Defteraios, Spyros ^a   Loutradi, Aphrodite ^c   Loukopoulos, Dimitrios ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b ATHENS NAVAL HOSPITAL   (Greece)

^c LAIKO GENERAL HOSPITAL   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

TETROFOSMIN TC 99M;

ADULT; AGE; ANGIOCARDIOGRAPHY; ARTICLE; BETA THALASSEMIA; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY DISEASE; ELECTROCARDIOGRAM; EVALUATION; FEMALE; HEART MUSCLE ISCHEMIA; HEART MUSCLE PERFUSION; HEART VENTRICLE HYPERTROPHY; HEMOGLOBIN DETERMINATION; HUMAN; LEUKOCYTE COUNT; MALE; MUSCLE CONTRACTILITY; PHYSICAL STRESS; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SCINTIGRAPHY; SEX DIFFERENCE; SICKLE CELL ANEMIA; SICKLE CELL TRAIT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; ST SEGMENT DEPRESSION; TREADMILL EXERCISE;

ADULT; ANALYSIS OF VARIANCE; ANEMIA, SICKLE CELL; BETA-THALASSEMIA; CORONARY CIRCULATION; EXERCISE TEST; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL ISCHEMIA; ORGANOPHOSPHORUS COMPOUNDS; ORGANOTECHNETIUM COMPOUNDS; RADIOPHARMACEUTICALS; STATISTICS, NONPARAMETRIC; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0035478101     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(01)00835-X     Document Type: Article

References (44)

1. Sickle cell disease
2. The heart in sickle cell anemia
3. Myocardial infarction with normal coronary arteries in S/beta thalassaemia patients
4. Biokinetics of technetium-99m-tetrofosmin. Myocardial perfusion imaging factor: Implications for one-day imaging protocol
5. Myocardial perfusion imaging and dynamic analysis with technetium 99m tetrofosmin
6. Simultaneous perfusion/function imaging
7. Dobutamine thallium myocardial perfusion tomography
8. Automatic quantification of ejection fraction from gated myocardial perfusion SPECT
9. Gated myocardial perfusion imaging for measuring left ventricular function
10. The cardiovascular manifestations of sickle cell disease
11. Sickle cell heart disease. Two-dimensional echo and Doppler ultrasonographic findings in the hearts of adult patients with sickle cell anemia
12. Myocardial infarction in sickle cell anemia
13. Sickle cell anemia: Does myocardial ischemia occur during crisis?
14. The heart in sickle cell anemia: The Cooperative Study of Sickle Cell Disease (CSSCD)
15. Cardiac size and function in children with sickle cell anemia
16. Cardiac function in sickle cell anemia
17. Clinicopathologic analysis of cardiac dysfunction in 52 patients with sickle cell anemia
18. The electrocardiogram and cardiac state in active sickle cell anemia
19. Cardiovascular findings in patients with sickle cell anemia
20. Scarring of the left ventricular papillary muscles in sickle-cell disease
21. Acute myocardial infarction in sickle cell anemia
22. Acute myocardial infarction in sickle cell disease: Case report and review of the literature
23. Massive nonatherosclerotic myocardial infarction in sickle cell anemia
24. Biventricular function in sickle-cell anemia: Radionuclide angiographic and thallium-201 scintigraphic evaluation
25. Exercise-induced cardiac dysfunction in sickle-cell anemia: A radionuclide study
26. Myocardial perfusion in children with sickle cell anaemia
27. Effects of hydroxyurea administration on the body weight, body composition and exercise performance of patients with sickle-cell anaemia
28. Exercise-induced death in sickle cell trait. Role of aging, training, and deconditioning
29. Blood polymorphonuclear leukocytes from the majority of sickle cell patients in the crisis phase of the disease show enhanced adhesion to vascular endothelium and increased expression of CD64
30. Raised neutrophil phospholipase A2 activity and defective priming of NADPH oxidase and phospholipase A2 in sickle cell disease
31. Current status of thalassemia and the sickle cell syndromes in Greece
32. Delay time of hemoglobin S polymerization prevents most cells from sickling in vivo
33. Circulating activated endothelial cells in sickle cell anemia
34. Sickle cell disease and the endothelium
35. Rheological predictors of the severity of the painful sickle-cell crises
36. Vascular occlusion in sickle cell disease. Current concepts and unanswered questions
37. Monoclonal antibodies to αβ3 (7E3 and LM609) inhibit sickle red blood cell-endothelium interactions induced by platelet-activating factor
38. Plasma levels of polymorphonuclear elastase and myeloperoxidase after uphill walking and downhill running at similar energy cost
39. Activation of leukocytes during prolonged physical exercise
40. Plasma elastase, alpha-1 antithrypsin, neopterin, tumor necrosis factor and soluble interleukin-2 receptor after prolonged exercise
41. Short-term changes in the immune system of elite swimmers under competition conditions: Different immunomodulation induced by various types of sport
42. Reaction patterns of blood platelets in exercise
43. Free radicals, exercise and antioxidant supplementation